CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autor principal: | Eva, Israt Ara Jannat |
---|---|
Altres autors: | Rahman, Kazi Fatema |
Format: | Thesis |
Idioma: | English |
Publicat: |
Brac University
2023
|
Matèries: | |
Accés en línia: | http://hdl.handle.net/10361/17764 |
Ítems similars
-
A review on CRISPR-Cas system based applications in Oncology
per: Sadia, Mir
Publicat: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
per: Maria, Amatul
Publicat: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
per: Nwabunwanne, Eze Uchenna
Publicat: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
per: Shaikat, Mahdi Mubin
Publicat: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
per: Ullah, Mohammad
Publicat: (2023)